2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site
- 28 January 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (4), 1803-1816
- https://doi.org/10.1021/acs.jmedchem.8b01766
Abstract
CK2 is a ubiquitous Ser/Thr protein kinase involved in the control of various signaling pathways and is known to be constitutively active. In the present study, we identified aryl 2-aminothiazoles as a novel class of CK2 inhibitors, which displayed a non-ATP-competitive mode of action and stabilized an inactive conformation of CK2 in solution. Enzyme kinetics studies, STD NMR, circular dichroism spectroscopy, and native mass spectrometry experiments demonstrated that the compounds bind in an allosteric pocket outside the ATP-binding site. Our data, combined with molecular docking studies, strongly suggested that this new binding site was located at the interface between the αC helix and the flexible glycine-rich loop. A first hit optimization led to compound 7, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile. Thus, we identified a novel class of CK2 inhibitors targeting an allosteric pocket, offering great potential for further optimization into anticancer drugs.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (EN381/2-3)
- R?gion Rh?ne-Alpes (?ARC 1 Sant?? 12-008707-01)
This publication has 39 references indexed in Scilit:
- A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066Bioorganic & Medicinal Chemistry, 2017
- A chemical with proven clinical safety restores Down syndrome-related phenotypes via DYRK1A inhibitionDisease Models & Mechanisms, 2016
- Identification of a Novel Function of CX-4945 as a Splicing RegulatorPLOS ONE, 2014
- Protein Kinase CK2Published by Wiley ,2013
- Antitumoral activity of allosteric inhibitors of protein kinase CK2Oncotarget, 2011
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor EfficacyCancer Research, 2010
- New Protein Kinase CK2 Inhibitors: Jumping out of the Catalytic BoxCell Chemical Biology, 2009
- Identification of Polyoxometalates as Nanomolar Noncompetitive Inhibitors of Protein Kinase CK2Cell Chemical Biology, 2008
- One‐thousand‐and‐one substrates of protein kinase CK2?The FASEB Journal, 2003
- Protein kinase CK2: structure, regulation and role in cellular decisions of life and deathBiochemical Journal, 2003